XML 29 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash Flows From Operating Activities:    
Net loss attributable to the Company $ (30,490) $ (81,331)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property, plant and equipment, and investment in leased property 1,481 1,438
Amortization of intangible assets 835 1,783
Stock-based compensation 5,835 2,403
Loss (gain) on acquisition activity, net 116 (1,014)
Gain on disposal of property, plant and equipment   (32)
Change in fair value of common stock warrant liability (4,603) 58,371
Changes in operating assets and liabilities that provide (use) cash, net of effects of acquisitions:    
Accounts receivable (1,536) (8,288)
Inventory (6,301) (6,358)
Prepaid expenses and other assets (8,127) (5,730)
Note receivable 48 47
Accounts payable, accrued expenses, product warranty reserve and other liabilities 5,325 6,031
Deferred revenue 121 1,655
Net cash used in operating activities (37,296) (31,025)
Cash Flows From Investing Activities:    
Purchase of property, plant and equipment (2,902) (1,200)
Cash acquired in purchase acquisitions 1,811 414
Proceeds from disposal of property, plant and equipment   32
Net cash used in investing activities (1,091) (754)
Cash Flows From Financing Activities:    
Change in restricted cash (29,686)  
Proceeds from exercise of warrants 25 18,340
Purchase of treasury stock   (514)
Proceeds from issuance of common stock and warrants   176,700
Stock issuance costs   (10,977)
Proceeds from exercise of stock options 166 241
Principal payments on obligations under capital lease (587) (576)
Proceeds from lease agreements recognized as finance obligations 7,224  
Net cash (used in) provided by financing activities (22,858) 183,214
Effect of exchange rate changes on cash 49  
(Decrease) increase in cash and cash equivalents (61,196) 151,435
Cash and cash equivalents, beginning of period 146,205 5,027
Cash and cash equivalents, end of period 85,009 156,462
Other Supplemental Cash Flow Information:    
Cash paid for interest 303 $ 337
Issuance of common stock for acquisition of HyPulsion $ 11,474